Neck injection showdown: which route eases arm pain best?
NCT ID NCT03389620
First seen Dec 26, 2025 · Last updated Jun 22, 2026 · Updated 22 times
Summary
This study compared two standard ways of giving steroid injections for nerve pain in the arm that comes from the neck. One method injects near the nerve root in the neck, the other in the back of the spine. Researchers measured pain relief in 74 adults to see if one route is safer or more effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICOGENIC UPPER EXTREMITY RADICULOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke Radiology and Orthopaedic Clinic
Durham, North Carolina, 27710, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dexamethasone (a corticosteroid)
What this could lead to
If this trial succeeds, it could show which injection method works better for arm nerve pain, helping doctors choose the safest and most effective option.
What could go wrong
This is a small, completed Phase 2 study with only 74 participants. Results may not apply to everyone, and the injections carry risks like infection or nerve damage, though rare.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.